Based on the above-described findings, we hypothesized that the serum levels of OXT in adolescent patients with treatment-resistant depression are higher than those in adolescents with non-treatment-resistant depression or normal controls, since children with treatment-resistant depression might develop bipolar disorder [9]. This evidence concerns the gene OXT and depressive symptom measurement.